PriceTargets.com logo

Intuitive Surgical - ISRG Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $554.17
  • Forecasted Upside: 5.67%
  • Number of Analysts: 19
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$524.43 As of 12/20/2024 06:45 PM ET
▲ +0.52 (0.10%)

This chart shows the closing price for ISRG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Intuitive Surgical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ISRG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ISRG

Analyst Price Target is $554.17
▲ +5.67% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $554.17, with a high forecast of $650.00 and a low forecast of $375.00. The average price target represents a 5.67% upside from the last price of $524.43.

This chart shows the closing price for ISRG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 19 contributing investment analysts is to moderate buy stock in Intuitive Surgical. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2023
  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2023
  • 0 strong buy ratings
  • 15 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2024
  • 0 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/21/2024
  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
11/20/2024
  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/18/2024Truist FinancialBoost TargetBuy ➝ Buy$570.00 ➝ $640.00
12/11/2024CitigroupBoost TargetBuy ➝ Buy$567.00 ➝ $640.00
12/11/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$549.00 ➝ $630.00
12/5/2024Stifel NicolausBoost TargetBuy ➝ Buy$525.00 ➝ $610.00
12/2/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight$522.00 ➝ $650.00
11/26/2024BTIG ResearchBoost TargetBuy ➝ Buy$535.00 ➝ $561.00
11/19/2024Erste Group BankUpgradeHold ➝ Buy
10/18/2024The Goldman Sachs GroupSet Target$604.00
10/18/2024OppenheimerReiterated RatingMarket Perform ➝ Market Perform
10/18/2024Evercore ISIReiterated RatingCautious ➝ Cautious
10/18/2024BTIG ResearchSet Target$535.00
10/18/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$475.00 ➝ $490.00
10/18/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$466.00 ➝ $549.00
10/18/2024Stifel NicolausBoost TargetBuy ➝ Buy$475.00 ➝ $525.00
10/18/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$495.00 ➝ $538.00
10/18/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$525.00 ➝ $555.00
10/17/2024MizuhoBoost Target$440.00 ➝ $500.00
10/17/2024Leerink PartnersBoost Target$489.00 ➝ $502.00
10/17/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$503.00 ➝ $565.00
10/14/2024BTIG ResearchBoost TargetBuy ➝ Buy$494.00 ➝ $518.00
10/14/2024Raymond JamesBoost TargetOutperform ➝ Outperform$500.00 ➝ $540.00
10/14/2024Truist FinancialBoost TargetBuy ➝ Buy$520.00 ➝ $570.00
10/11/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$495.00 ➝ $575.00
10/8/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$515.00 ➝ $525.00
10/1/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$410.00 ➝ $475.00
8/28/2024BTIG ResearchBoost TargetBuy ➝ Buy$469.00 ➝ $494.00
8/22/2024CitigroupBoost TargetBuy ➝ Buy$512.00 ➝ $560.00
8/2/2024Redburn AtlanticUpgradeNeutral ➝ Buy$380.00 ➝ $510.00
7/19/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$475.00 ➝ $495.00
7/19/2024Stifel NicolausBoost TargetBuy ➝ Buy$430.00 ➝ $475.00
7/19/2024Evercore ISILower TargetIn-Line ➝ In-Line$425.00 ➝ $410.00
7/19/2024Piper SandlerBoost TargetOverweight ➝ Overweight$490.00 ➝ $495.00
7/19/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$487.00 ➝ $503.00
7/18/2024BarclaysBoost TargetOverweight ➝ Overweight$430.00 ➝ $490.00
7/16/2024Truist FinancialBoost TargetBuy ➝ Buy$450.00 ➝ $515.00
7/15/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$375.00 ➝ $460.00
7/15/2024BTIG ResearchBoost TargetBuy ➝ Buy$451.00 ➝ $459.00
7/10/2024CitigroupBoost TargetBuy ➝ Buy$462.00 ➝ $512.00
7/9/2024Piper SandlerBoost TargetOverweight ➝ Overweight$435.00 ➝ $490.00
7/2/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$385.00 ➝ $425.00
5/30/2024The Goldman Sachs GroupInitiated CoverageBuy$500.00
4/19/2024Piper SandlerBoost TargetOverweight ➝ Overweight$425.00 ➝ $435.00
4/19/2024BTIG ResearchBoost TargetBuy ➝ Buy$412.00 ➝ $421.00
4/19/2024Robert W. BairdLower TargetOutperform ➝ Outperform$440.00 ➝ $436.00
4/19/2024Jefferies Financial GroupBoost TargetHold ➝ Hold$365.00 ➝ $375.00
4/8/2024Stifel NicolausBoost TargetBuy ➝ Buy$420.00 ➝ $430.00
4/3/2024CitigroupBoost TargetBuy ➝ Buy$428.00 ➝ $462.00
3/15/2024Stifel NicolausReiterated RatingBuy ➝ Buy$420.00
1/25/2024MizuhoBoost TargetNeutral ➝ Neutral$350.00 ➝ $390.00
1/25/2024Raymond JamesBoost TargetOutperform ➝ Outperform$372.00 ➝ $435.00
1/25/2024BarclaysBoost TargetOverweight ➝ Overweight$385.00 ➝ $430.00
1/24/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$400.00 ➝ $432.00
1/24/2024Truist FinancialBoost TargetBuy ➝ Buy$390.00 ➝ $435.00
1/24/2024Stifel NicolausBoost TargetBuy ➝ Buy$360.00 ➝ $420.00
1/24/2024Piper SandlerBoost TargetOverweight ➝ Overweight$325.00 ➝ $425.00
1/19/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$363.00 ➝ $416.00
1/12/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$380.00 ➝ $400.00
1/3/2024Raymond JamesBoost TargetOutperform ➝ Outperform$310.00 ➝ $372.00
12/22/2023Truist FinancialBoost TargetBuy ➝ Buy$375.00 ➝ $390.00
12/12/2023Truist FinancialBoost TargetBuy ➝ Buy$320.00 ➝ $375.00
12/4/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$300.00 ➝ $330.00
11/17/2023Stifel NicolausBoost TargetBuy ➝ Buy$315.00 ➝ $350.00
11/17/2023HSBCInitiated CoverageBuy$318.00
10/23/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$330.00 ➝ $300.00
10/20/2023Piper SandlerLower TargetOverweight ➝ Overweight$385.00 ➝ $325.00
10/20/2023CitigroupLower TargetBuy ➝ Buy$400.00 ➝ $390.00
10/20/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$355.00
10/20/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$386.00 ➝ $363.00
10/20/2023Raymond JamesLower TargetOutperform ➝ Outperform$368.00 ➝ $310.00
10/19/2023UBS GroupLower TargetNeutral ➝ Neutral$385.00 ➝ $314.00
10/16/2023Leerink PartnersInitiated CoverageOutperform$342.00
8/17/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$360.00
7/24/2023Morgan StanleyBoost TargetEqual Weight$310.00 ➝ $330.00
7/24/2023Raymond JamesBoost TargetOutperform$323.00 ➝ $368.00
7/24/2023BarclaysBoost TargetOverweight$314.00 ➝ $385.00
7/21/2023JPMorgan Chase & Co.Boost TargetOverweight$335.00 ➝ $365.00
7/21/2023Piper SandlerBoost TargetOverweight$315.00 ➝ $385.00
7/21/2023Royal Bank of CanadaBoost TargetOutperform$355.00 ➝ $360.00
7/21/2023Wells Fargo & CompanyBoost TargetOverweight$310.00 ➝ $386.00
7/19/2023Truist FinancialBoost Target$347.00 ➝ $400.00
7/18/2023Robert W. BairdInitiated CoverageOutperform$377.00
7/17/2023BTIG ResearchBoost Target$326.00 ➝ $373.00
7/17/2023MizuhoBoost Target$300.00 ➝ $370.00
7/12/2023Royal Bank of CanadaBoost Target$309.00 ➝ $355.00
7/10/2023CitigroupBoost Target$317.00 ➝ $400.00
6/5/2023BTIG ResearchBoost Target$313.00 ➝ $326.00
5/31/2023Sanford C. BernsteinBoost Target$350.00 ➝ $365.00
5/18/2023Truist FinancialBoost Target$325.00 ➝ $347.00
4/20/2023Sanford C. BernsteinBoost TargetOutperform$325.00 ➝ $350.00
4/19/2023BarclaysBoost TargetOverweight$298.00 ➝ $314.00
4/19/2023Deutsche Bank AktiengesellschaftBoost TargetHold$245.00 ➝ $290.00
4/19/2023Stifel NicolausBoost TargetBuy$285.00 ➝ $315.00
4/19/2023JPMorgan Chase & Co.Boost TargetOverweight$250.00 ➝ $335.00
4/19/2023Piper SandlerBoost TargetOverweight$265.00 ➝ $315.00
4/19/2023Royal Bank of CanadaBoost TargetOutperform$305.00 ➝ $309.00
4/19/2023Evercore ISIBoost TargetInline$240.00 ➝ $270.00
4/19/2023Morgan StanleyBoost TargetEqual Weight$265.00 ➝ $285.00
4/19/2023Truist FinancialBoost TargetBuy$300.00 ➝ $325.00
4/19/2023Bank of AmericaBoost TargetBuy$300.00 ➝ $315.00
4/19/2023Wells Fargo & CompanyBoost TargetOverweight$289.00 ➝ $310.00
4/19/2023Raymond JamesBoost TargetOutperform$270.00 ➝ $323.00
4/19/2023CitigroupBoost TargetBuy$305.00 ➝ $317.00
4/18/2023MizuhoBoost TargetNeutral$240.00 ➝ $250.00
4/17/2023BTIG ResearchBoost TargetBuy$279.00 ➝ $284.00
4/4/2023Evercore ISIBoost TargetIn-Line$215.00 ➝ $240.00
3/28/2023UBS GroupInitiated CoverageNeutral$278.00
3/23/2023William BlairInitiated CoverageOutperform
1/26/2023Raymond JamesBoost TargetOutperform$255.00 ➝ $270.00
1/25/2023Morgan StanleyLower TargetEqual Weight$290.00 ➝ $265.00
1/25/2023Deutsche Bank AktiengesellschaftBoost Target$230.00 ➝ $245.00
1/25/2023BTIG ResearchLower TargetBuy$316.00 ➝ $279.00
1/25/2023Truist FinancialLower TargetBuy$310.00 ➝ $300.00
1/25/2023Wells Fargo & CompanyLower TargetOverweight$305.00 ➝ $289.00
1/25/2023MizuhoLower Target$245.00 ➝ $240.00
1/25/2023CitigroupLower TargetBuy$318.00 ➝ $305.00
1/24/2023MizuhoBoost TargetNeutral$215.00 ➝ $245.00
1/6/2023Morgan StanleyBoost TargetEqual Weight$235.00 ➝ $290.00
1/4/2023BarclaysBoost Target$235.00 ➝ $298.00
12/22/2022ArgusBoost TargetBuy$265.00 ➝ $320.00
12/20/2022Truist FinancialBoost TargetBuy$300.00 ➝ $310.00
12/12/2022Wells Fargo & CompanyBoost TargetOverweight$262.00 ➝ $305.00
12/12/2022CitigroupBoost Target$245.00 ➝ $318.00
12/5/2022BTIG ResearchBoost TargetBuy$247.00 ➝ $316.00
11/18/2022JPMorgan Chase & Co.Boost TargetOverweight$250.00 ➝ $280.00
11/14/2022Truist FinancialBoost Target$260.00 ➝ $300.00
10/20/2022Deutsche Bank AktiengesellschaftBoost TargetHold$205.00 ➝ $230.00
10/19/2022Morgan StanleyBoost TargetEqual Weight$215.00 ➝ $235.00
10/19/2022Truist FinancialBoost Target$230.00 ➝ $260.00
10/19/2022Wells Fargo & CompanyLower TargetOverweight$265.00 ➝ $248.00
10/19/2022Piper SandlerBoost TargetOverweight$260.00 ➝ $265.00
10/17/2022BarclaysInitiated CoverageOverweight$235.00
10/17/2022Truist FinancialLower TargetBuy$255.00 ➝ $230.00
10/12/2022MizuhoInitiated CoverageNeutral$215.00
10/12/2022Jefferies Financial GroupInitiated CoverageHold$210.00
10/11/2022Morgan StanleyLower TargetEqual Weight$225.00 ➝ $215.00
10/5/2022CitigroupLower Target$243.00 ➝ $237.00
9/9/2022Stifel NicolausBoost TargetBuy$250.00 ➝ $260.00
8/18/2022Piper SandlerBoost TargetOverweight$255.00 ➝ $260.00
7/29/2022The Goldman Sachs GroupLower TargetBuy$319.00 ➝ $273.00
7/22/2022Wells Fargo & CompanyLower Target$265.00
7/22/2022Truist FinancialLower TargetBuy$270.00 ➝ $255.00
7/22/2022Evercore ISILower Target$210.00 ➝ $175.00
7/22/2022Deutsche Bank AktiengesellschaftLower Target$225.00 ➝ $205.00
7/22/2022Raymond JamesLower Target$294.00 ➝ $255.00
7/22/2022Piper SandlerLower TargetOverweight$316.00 ➝ $255.00
7/18/2022BTIG ResearchLower TargetBuy$355.00 ➝ $247.00
7/18/2022Stifel NicolausLower Target$325.00 ➝ $270.00
7/15/2022Morgan StanleyLower TargetEqual Weight$300.00 ➝ $225.00
7/13/2022Truist FinancialLower TargetBuy$355.00 ➝ $270.00
6/22/2022Deutsche Bank AktiengesellschaftLower TargetHold$300.00 ➝ $225.00
6/3/2022Piper SandlerReiterated RatingBuy$316.00
5/17/2022CitigroupLower Target$360.00 ➝ $305.00
4/25/2022Morgan StanleyLower TargetEqual Weight$325.00 ➝ $300.00
4/22/2022Wells Fargo & CompanyLower TargetOverweight$350.00 ➝ $339.00
4/22/2022Evercore ISILower Target$294.00 ➝ $280.00
4/22/2022Raymond JamesLower TargetOutperform$334.00 ➝ $330.00
4/22/2022Piper SandlerBoost TargetOverweight$310.00 ➝ $316.00
4/12/2022Truist FinancialInitiated CoverageBuy$360.00
4/5/2022Wolfe ResearchInitiated CoveragePeer Perform$315.00
3/25/2022Royal Bank of CanadaInitiated CoverageOutperform$340.00
3/1/2022Bank of AmericaInitiated CoverageBuy ➝ Buy
2/2/2022UBS GroupUpgradeNeutral ➝ Buy$317.00 ➝ $325.00
1/31/2022Piper SandlerUpgradeNeutral ➝ Overweight$300.00 ➝ $310.00
1/25/2022Redburn PartnersDowngradeBuy ➝ Neutral
1/21/2022BTIG ResearchLower TargetBuy$372.00 ➝ $360.00
1/21/2022Evercore ISILower TargetInline$340.00 ➝ $290.00
1/21/2022UBS GroupLower TargetNeutral$338.00 ➝ $317.00
1/21/2022Morgan StanleyLower TargetEqual Weight$375.00 ➝ $325.00
1/21/2022Stifel NicolausLower TargetBuy$370.00 ➝ $325.00
1/21/2022Raymond JamesLower TargetOutperform$383.00 ➝ $334.00
1/21/2022Wells Fargo & CompanyLower TargetOverweight$381.00 ➝ $350.00
1/21/2022Deutsche Bank AktiengesellschaftLower TargetHold$323.00 ➝ $300.00
1/21/2022Robert W. BairdLower TargetOutperform$370.00 ➝ $315.00
1/21/2022CitigroupUpgradeNeutral ➝ Buy$370.00 ➝ $360.00
1/21/2022Piper SandlerLower TargetNeutral$330.00 ➝ $300.00
1/10/2022BTIG ResearchUpgradeNeutral ➝ Buy$372.00
1/7/2022Morgan StanleyBoost TargetEqual Weight$325.00 ➝ $375.00
12/16/2021The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy
10/21/2021Morgan StanleyBoost TargetEqual Weight$310.00 ➝ $325.00
10/20/2021UBS GroupBoost TargetNeutral$323.00 ➝ $352.00
10/20/2021Wells Fargo & CompanyBoost TargetOverweight$354.00 ➝ $381.00
10/20/2021Deutsche Bank AktiengesellschaftBoost TargetHold$306.00 ➝ $323.00
10/20/2021Robert W. BairdBoost TargetOutperform$350.00 ➝ $370.00
10/20/2021Piper SandlerBoost TargetNeutral$323.00 ➝ $330.00
10/5/2021Morgan StanleyLower TargetEqual Weight$323.50 ➝ $310.00
10/1/2021CitigroupDowngradeBuy ➝ Neutral$366.67
9/28/2021Raymond JamesInitiated CoverageBuy$383.33
8/26/2021Leerink PartnersBoost TargetMarket Perform$325.00 ➝ $346.67
7/22/2021Deutsche Bank AktiengesellschaftBoost TargetHold$275.00 ➝ $308.33
7/21/2021Leerink PartnersBoost TargetMarket Perform$310.00 ➝ $325.00
7/21/2021UBS GroupBoost TargetNeutral$296.67 ➝ $323.33
7/21/2021JPMorgan Chase & Co.Boost TargetOverweight$300.00 ➝ $333.33
7/21/2021Bank of AmericaBoost TargetNeutral$296.67 ➝ $340.00
7/21/2021Evercore ISIBoost TargetIn-Line$275.00 ➝ $326.67
7/21/2021Morgan StanleyBoost TargetEqual Weight$285.00 ➝ $310.00
7/21/2021Wells Fargo & CompanyBoost TargetPositive ➝ Overweight$305.33 ➝ $353.33
7/21/2021Robert W. BairdBoost TargetSell ➝ Outperform$275.00 ➝ $350.00
7/21/2021CitigroupBoost TargetBuy$313.00 ➝ $366.67
7/21/2021Piper SandlerBoost TargetNeutral$280.00 ➝ $323.33
7/14/2021The Goldman Sachs GroupBoost TargetBuy$317.67 ➝ $363.33
7/14/2021Stifel NicolausBoost TargetBuy$320.00 ➝ $353.33
6/7/2021Wells Fargo & CompanyBoost TargetPositive ➝ Overweight$297.33 ➝ $305.33
4/21/2021CitigroupBoost Target$287.33 ➝ $313.00
4/21/2021Morgan StanleyBoost TargetEqual Weight$260.00 ➝ $285.00
4/21/2021Leerink PartnersBoost TargetMarket Perform$275.00 ➝ $286.67
4/21/2021Wells Fargo & CompanyBoost TargetOverweight$293.00 ➝ $297.33
4/21/2021Deutsche Bank AktiengesellschaftBoost TargetHold$230.00 ➝ $275.00
4/21/2021JPMorgan Chase & Co.Boost TargetOverweight$280.00 ➝ $300.00
4/21/2021Piper SandlerBoost TargetNeutral$245.00 ➝ $280.00
4/21/2021Robert W. BairdUpgradeNeutral ➝ Outperform$275.00 ➝ $308.33
4/21/2021OppenheimerUpgradeUnderperform ➝ Market Perform
4/1/2021CitigroupInitiated CoverageBuy$287.33
3/31/2021Piper SandlerBoost TargetNeutral$243.33 ➝ $245.00
1/22/2021JPMorgan Chase & Co.Boost TargetOverweight$275.00 ➝ $280.00
1/22/2021Raymond JamesBoost TargetOutperform$266.67 ➝ $288.33
1/22/2021Wells Fargo & CompanyBoost TargetOverweight$280.33 ➝ $293.00
1/22/2021OppenheimerBoost TargetUnderperform$121.67 ➝ $136.67
1/22/2021Piper SandlerBoost TargetNeutral$226.67 ➝ $243.33
12/15/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight$260.00
10/16/2020Leerink PartnersBoost TargetMarket Perform$230.00 ➝ $241.67
10/16/2020JPMorgan Chase & Co.Boost TargetOverweight$255.00 ➝ $261.67
10/16/2020Stifel NicolausBoost TargetBuy$241.67 ➝ $271.67
10/16/2020Wells Fargo & CompanyBoost TargetOverweight$242.33 ➝ $271.67
10/16/2020Morgan StanleyBoost TargetOverweight$245.00 ➝ $261.67
10/16/2020Piper SandlerBoost TargetNeutral$198.33 ➝ $226.67
10/15/2020BTIG ResearchReiterated RatingHold
10/12/2020Raymond JamesBoost TargetOutperform$241.67 ➝ $266.67
9/28/2020ArgusInitiated CoverageBuy$258.33
9/14/2020BTIG ResearchReiterated RatingHold
9/11/2020Wolfe ResearchInitiated CoverageOutperform$263.00
9/8/2020Bank of AmericaDowngradeBuy ➝ Neutral$241.67 ➝ $253.33
9/1/2020Robert W. BairdInitiated CoverageNeutral$233.33
8/14/2020Leerink PartnersBoost TargetMarket Perform$216.67 ➝ $230.00
8/3/2020BTIG ResearchReiterated RatingHold
7/22/2020JPMorgan Chase & Co.Boost TargetOverweight$200.00 ➝ $233.33
7/22/2020UBS GroupBoost TargetNeutral$188.33 ➝ $223.33
7/22/2020Deutsche Bank AktiengesellschaftBoost TargetHold$166.67 ➝ $200.00
7/22/2020Morgan StanleyBoost TargetOverweight$200.67 ➝ $245.00
7/22/2020Leerink PartnersBoost TargetMarket Perform$196.67 ➝ $216.67
7/22/2020Raymond JamesBoost TargetOutperform$200.00 ➝ $241.67
7/22/2020Piper SandlerBoost TargetNeutral$170.00 ➝ $198.33
7/22/2020Wells Fargo & CompanyBoost TargetOverweight$210.67 ➝ $242.33
7/20/2020Sanford C. BernsteinBoost TargetOutperform$208.33 ➝ $241.67
7/20/2020Stifel NicolausBoost TargetBuy$191.67 ➝ $238.33
7/15/2020Leerink PartnersBoost TargetMarket Perform$178.33 ➝ $196.67
7/13/2020Sanford C. BernsteinReiterated RatingBuy$208.33
6/18/2020JPMorgan Chase & Co.Boost TargetOverweight$188.33 ➝ $200.00
6/16/2020OTR GlobalDowngradePositive
6/4/2020Wells Fargo & CompanyBoost TargetOverweight$187.00 ➝ $210.67
4/28/2020OppenheimerReiterated RatingSell$121.67
4/28/2020Piper SandlerDowngradeOverweight ➝ Neutral$190.00 ➝ $170.00
4/19/2020Evercore ISIDowngradeIn-Line ➝ Underperform
4/17/2020UBS GroupLower TargetNeutral$206.67 ➝ $188.33
4/17/2020CfraDowngradeHold ➝ Sell
4/17/2020Piper SandlerLower Target$211.00 ➝ $190.00
4/17/2020Wells Fargo & CompanyBoost TargetOverweight$185.00 ➝ $187.00
4/17/2020Deutsche Bank AktiengesellschaftLower TargetHold$198.33 ➝ $166.67
4/17/2020Stifel NicolausBoost TargetBuy$141.67 ➝ $191.67
4/17/2020Leerink PartnersDowngradeOutperform ➝ Market Perform$191.67 ➝ $178.33
4/17/2020BTIG ResearchReiterated RatingHold
4/13/2020Raymond JamesLower TargetOutperform$220.00 ➝ $200.00
4/9/2020Bank of AmericaReiterated RatingBuy$216.67
4/9/2020Evercore ISIDowngradeIn-Line ➝ Underperform
4/8/2020Piper SandlerReiterated RatingBuy$211.00
4/2/2020Wells Fargo & CompanyLower TargetOverweight$218.33 ➝ $181.67
4/1/2020The Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy
4/1/2020OppenheimerDowngradeMarket Perform ➝ Underperform$121.67
3/27/2020Morgan StanleyLower TargetOverweight$223.33 ➝ $207.33
3/24/2020Stifel NicolausLower TargetBuy$221.67 ➝ $141.67
3/17/2020JPMorgan Chase & Co.Lower TargetOverweight$221.67 ➝ $191.67
2/12/2020The Goldman Sachs GroupInitiated CoverageBuy$241.67
1/27/2020Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$203.33 ➝ $198.33
1/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight$191.67 ➝ $221.67
1/24/2020Raymond JamesBoost TargetOutperform$205.00 ➝ $220.00
1/10/2020UBS GroupBoost TargetNeutral$196.67 ➝ $206.67
1/10/2020Cantor FitzgeraldReiterated RatingOverweight$206.67 ➝ $230.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.36 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 54 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
5/25/2024
  • 54 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 55 very positive mentions
  • 21 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 43 very positive mentions
  • 25 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 48 very positive mentions
  • 27 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 37 very positive mentions
  • 31 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 104 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 101 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 101 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Intuitive Surgical logo
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $524.43
Low: $516.18
High: $530.97

50 Day Range

MA: $526.84
Low: $473.73
High: $550.43

52 Week Range

Now: $524.43
Low: $320.26
High: $556.23

Volume

3,890,647 shs

Average Volume

1,452,786 shs

Market Capitalization

$186.79 billion

P/E Ratio

84.31

Dividend Yield

N/A

Beta

1.38

Frequently Asked Questions

What sell-side analysts currently cover shares of Intuitive Surgical?

The following Wall Street research analysts have issued research reports on Intuitive Surgical in the last year: Barclays PLC, BTIG Research, Citigroup Inc., Erste Group Bank AG, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Leerink Partners, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Redburn Atlantic, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for ISRG.

What is the current price target for Intuitive Surgical?

0 Wall Street analysts have set twelve-month price targets for Intuitive Surgical in the last year. Their average twelve-month price target is $554.17, suggesting a possible upside of 5.7%. Morgan Stanley has the highest price target set, predicting ISRG will reach $650.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $375.00 for Intuitive Surgical in the next year.
View the latest price targets for ISRG.

What is the current consensus analyst rating for Intuitive Surgical?

Intuitive Surgical currently has 1 sell rating, 3 hold ratings and 15 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ISRG.

What other companies compete with Intuitive Surgical?

Other companies that are similar to Intuitive Surgical include Abbott Laboratories, Stryker, Boston Scientific, Medtronic and Becton, Dickinson and Company. Learn More about companies similar to Intuitive Surgical.

How do I contact Intuitive Surgical's investor relations team?

Intuitive Surgical's physical mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider's listed phone number is (408) 523-2100 and its investor relations email address is [email protected]. The official website for Intuitive Surgical is www.intuitive.com. Learn More about contacing Intuitive Surgical investor relations.